Risk factors for postherpetic neuralgia in patients with herpes zoster

被引:289
|
作者
Jung, BF
Johnson, RW
Griffin, DRJ
Dworkin, RH
机构
[1] Univ Rochester, Sch Med & Dent, Rochester, NY 14642 USA
[2] Univ Bristol, Bristol, Avon, England
[3] Bristol Royal Infirm & Gen Hosp, Bristol, Avon, England
[4] GlaxoSmithKline, Harlow, Essex, England
关键词
D O I
10.1212/01.WNL.0000123261.00004.29
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives: To identify risk factors for postherpetic neuralgia (PHN) using a validated definition of this chronic neuropathic pain syndrome, to determine combinations of risk factors that identify patients with a high risk of developing PHN, and to examine the characteristics of patients with subacute herpetic neuralgia, that is, pain that persists beyond the acute phase of herpes zoster but that resolves before PHN can be diagnosed. Methods: The authors examined baseline and follow-up data from 965 herpes zoster patients enrolled within 72 hours of rash onset in two clinical trials of famciclovir. Results: Univariate and multivariate analyses indicated that older age, female sex, presence of a prodrome, greater rash severity, and greater acute pain severity made independent contributions to identifying which patients developed PHN. Patients with subacute herpetic neuralgia who did not develop PHN were significantly younger and had less severe acute pain than PHN patients but were significantly more likely to have severe and widespread rash than patients without persisting pain. Conclusions: The independent contributions to the prediction of PHN made by older age, female sex, presence of a prodrome, greater rash severity, and greater acute pain severity suggest that these risk factors reflect different mechanisms that each contribute to the development of PHN. Subacute herpetic neuralgia that does not progress to PHN may reflect peripheral tissue damage and inflammation caused by a particularly severe or widespread rash.
引用
收藏
页码:1545 / 1551
页数:7
相关论文
共 50 条
  • [31] IS POSTHERPETIC NEURALGIA AN INEVITABLE END IN ELDERLY CASES WITH HERPES ZOSTER? AN EVALUATION OF AGE-RELATED RISK FACTORS IN THE DEVELOPMENT OF POSTHERPETIC NEURALGIA
    Yuruk, Damla
    Tabakoglu, Aycin Yildiz
    TURKISH JOURNAL OF GERIATRICS-TURK GERIATRI DERGISI, 2021, 24 (01): : 41 - 49
  • [32] Postherpetic Neuralgia After Herpes Zoster Vaccination
    Lambert, Stephen Bernard
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 308 (14): : 1427 - 1427
  • [33] Herpes Zoster and Postherpetic Neuralgia in Older Adults
    Schmader, Kenneth
    CLINICS IN GERIATRIC MEDICINE, 2007, 23 (03) : 615 - +
  • [34] Plasma Proteomic Analysis of Patients With Herpes Zoster to Identify Predictors of Postherpetic Neuralgia Risk
    Zhang, Tianqi
    Wang, Naikun
    Zhu, Tong
    Xu, Jin
    Tan, Mengjiao
    Wang, Ran
    Han, Ying
    EUROPEAN JOURNAL OF PAIN, 2025, 29 (05)
  • [35] Immune Dysregulation in Acute Herpes Zoster: Predictive Factors for Postherpetic Neuralgia
    Wang, Meidi
    Yuan, Yanrong
    Wang, Jun
    Yan, Yongxing
    Yu, Huiqin
    MEDICAL SCIENCE MONITOR, 2025, 31
  • [36] TREATMENT OF HERPES-ZOSTER AND POSTHERPETIC NEURALGIA
    CARMICHAEL, JK
    AMERICAN FAMILY PHYSICIAN, 1991, 44 (01) : 203 - 210
  • [37] Herpes zoster infection and postherpetic neuralgia.
    Tenser R.B.
    Current Neurology and Neuroscience Reports, 2001, 1 (6) : 526 - 532
  • [38] Herpes Zoster and Postherpetic Neuralgia: Prevention and Management
    Saguil, Aaron
    Kane, Shawn
    Mercado, Michael
    Lauters, Rebecca
    AMERICAN FAMILY PHYSICIAN, 2017, 96 (10) : 656 - 663
  • [39] TREATMENT OF HERPES-ZOSTER AND POSTHERPETIC NEURALGIA
    SANCHEZ, JLA
    MEDICINA CLINICA, 1991, 97 (20): : 789 - 790
  • [40] Vaccination to prevent herpes zoster and postherpetic neuralgia
    Oxman, Michael N.
    HUMAN VACCINES, 2007, 3 (02): : 64 - 68